MapLight Therapeutics, Inc. — Investor Relations & Filings
About MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for central nervous system (CNS) disorders. The company leverages a proprietary platform rooted in circuit-level neuroscience to identify and modulate specific neural circuits associated with disease pathology. This approach is designed to create more effective and better-tolerated treatments by addressing the underlying circuit dysfunction rather than broad neurotransmitter imbalances. MapLight’s development pipeline includes therapeutic candidates for Autism Spectrum Disorder, Parkinson’s Disease, and Schizophrenia, with several programs in clinical and preclinical stages. The company aims to redefine the standard of care for patients suffering from complex neuropsychiatric and neurological conditions through its circuit-based discovery engine.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-02-09 | English | |
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-02-05 | English | |
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-31 | English | |
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | |
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | |
| 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 32897989 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-02-09 | English | ||
| 32897990 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-02-05 | English | ||
| 32897991 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-31 | English | ||
| 32897992 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897993 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897994 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897996 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897995 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897997 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897998 | 4 - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-29 | English | ||
| 32897999 | 8-K - MAPLIGHT THERAPEUTICS, INC. (0001770069) (Filer) | 2026-01-09 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
MapLight Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51538/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51538 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51538 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51538 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51538}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MapLight Therapeutics, Inc. (id: 51538)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.